Faecal microbiota transplantation (FMT) is a medical procedure in which gut microbiota from a carefully selected and screened donor is transferred to a patient with the aim of restoring or altering the gut microbial environment.
FMT is used primarily in cases of recurrent Clostridioides difficile infection, whilst its potential use in other conditions continues to be investigated.
Before the procedure is carried out, it is important for the patient to undergo a medical assessment and receive clear information about the potential benefits and risks.
In FMT, material from a pre-screened donor is transferred to the patient’s digestive system. The aim is to influence the composition and function of the gut microbiota.
This is not simply a matter of „adding good bacteria“. The gut microbiome is a complex ecosystem comprising a multitude of microorganisms that interact with one another and with the body.
Not every patient with gut-related symptoms is a suitable candidate for FMT. Before the procedure, the doctor must assess the patient’s medical history, current symptoms, diagnoses, previous treatments and medication.
Depending on the specific case, further investigations may be necessary.
FMT should therefore not be regarded as a one-size-fits-all solution for dysbiosis, bloating or other non-specific intestinal symptoms.
The safety of FMT depends to a large extent on the careful selection and screening of the donor.
Potential donors are assessed according to pre-defined criteria and screened for various infectious agents and other risk factors. It is important to note that it is not safe to perform FMT using material from a random or unverified donor.
Preparation depends on the specific protocol and method of FMT administration. In some cases, it may be necessary to cleanse the large intestine beforehand.
The medical team provides specific instructions regarding diet, fluid intake and medication prior to the procedure. It is important that the patient follows these instructions and informs the doctor of any medication and supplements they are taking.
FMT is a medical procedure and is not entirely without risk.
Temporary symptoms such as bloating, flatulence, abdominal discomfort or changes in bowel habits may occur. There is also a risk of transmitting infectious agents, which makes careful donor screening extremely important.
The potential benefits and risks should be discussed with a doctor before the procedure.
The response to FMT varies from person to person and depends on the reason for the procedure, the patient’s condition and other factors.
FMT does not guarantee a specific outcome, particularly when used for conditions for which the method is still being researched.
If any unusual or severe symptoms occur following the procedure, the patient should contact the medical team.
At the Unimed Medical Centre, patients interested in FMT undergo a medical assessment prior to the procedure.
The patient completes a detailed medical questionnaire, which is reviewed by a doctor. Following this assessment, a decision is made as to whether FMT is appropriate in this particular case and which approach is most suitable.
The procedure is carried out by Dr Todor Hinov, who has many years’ experience in the field of the gut microbiome and FMT.
FMT is an emerging approach in the field of the gut microbiome, with well-established applications for certain medical conditions and ongoing research into other potential applications.
If you are considering a faecal transplant, the most important first step is a medical assessment. This enables healthcare professionals to determine whether the procedure is suitable for the individual patient and to discuss the potential benefits, risks and alternatives.
Contact us for a consultation, research information or partnership. We will assist you with care and professionalism.
